Therapeutic Advances in Neurodegeneration With Brain Iron Accumulation

Research output: Contribution to journalArticlepeer-review


Neurodegeneration with brain iron accumulation (NBIA) includes a heterogeneous group of genetically defined disorders characterized by progressive extrapyramidal deterioration and iron accumulation in the basal ganglia. Current medical options for these disorders remain largely unsatisfactory and do not prevent the disease from progressing to a severe and disabling state. In select cases, surgical techniques, such as deep brain stimulation, may be effective in ameliorating some of the symptoms of the disease. The availability of chelating agents with specific properties that have been demonstrated to be effective in other disorders with regional iron accumulation as well as magnetic resonance imaging techniques that allow for quantitative assessment of iron have stimulated interest in the use of chelating agents in NBIA. This review aims to describe the role of surgical therapies in NBIA, discuss the use of chelating agents in NBIA, and presents new therapeutic approaches under consideration.

Original languageEnglish
Pages (from-to)82-86
Number of pages5
JournalSeminars in Pediatric Neurology
Issue number2
Publication statusPublished - Jun 2012

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Therapeutic Advances in Neurodegeneration With Brain Iron Accumulation'. Together they form a unique fingerprint.

Cite this